A case of extramammary Paget's disease treated with 5% imiquimod cream

Myeung Hun Choi, Jie Hyun Jeon, Sang Wook Son, Il Hwan Kim

Research output: Contribution to journalArticlepeer-review


Extramammary Paget's disease (EMPD) is a rare intraepidermal adenocarcinoma. Mohs micrographic surgery is considered the standard treatment. Other treatment modalities such as surgical excision, radiotherapy, topical chemotherapy, and photodynamic therapy are associated with varying degrees of effectiveness, and possible loss of tissue function and disease recurrence are seen. The search for an effective, safe treatment with minimal side effects proves to be challenging. Imiquimod is the first representative of a new class of immunomodulating drugs demonstrating potent antiviral and antitumor activity, and has been approved by the FDA for treating anogenital warts, actinic keratosis and basal cell carcinoma. Recent research has demonstrated its effective usage as a 5% cream in the management of EMPD. We report a case of EMPD of the scrotum successfully treated with topical 5% imiquimod cream. This has never been published in the Korea dermatologic literature.

Original languageEnglish
Pages (from-to)365-368
Number of pages4
JournalKorean Journal of Dermatology
Issue number3
Publication statusPublished - 2006 Mar


  • Extramammary Paget's disease
  • Imiquimod

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'A case of extramammary Paget's disease treated with 5% imiquimod cream'. Together they form a unique fingerprint.

Cite this